EUVIMEDEUVIMED entdecken
FallberichtKlinische StudieOpen Access · CC BY-NC 3.0

The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects

Yue Liu, Chenguang Yang, Wenyuan Qi, Zuowei Pei iD, Wei Xue, Huolan Zhu, Min Dong, Ying Guo, Duanduan Cong, Fang Wang

Pharmacogenomics and Personalized Medicine · 2021-04 · Volume 14 · 477-485

DOI: 10.2147/pgpm.s291723 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2021-04. Verfasst von Yue Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ABCB1CES1anticoagulantsdabigatrangeneticspharmacogenetics

Autor:innen und Institutionen

  • Clinical Trial Center, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Beijing Ho…
  • Internal Medicine-Cardiovascular Department, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital, Beijing, People's Republic of China.

ORCID-Profile: Zuowei Pei

Zitieren

APA

Liu, Y., Yang, C., Qi, W., Pei, Z., Xue, W., Zhu, H., Dong, M., Guo, Y., Cong, D., & Wang, F. (2021). The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects. Pharmacogenomics and Personalized Medicine, Volume 14, 477-485. https://doi.org/10.2147/pgpm.s291723

Vancouver

Liu Y, Yang C, Qi W, Pei Z, Xue W, Zhu H, et al. The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects. Pharmacogenomics and Personalized Medicine. 2021;Volume 14:477-485. doi:10.2147/pgpm.s291723

BibTeX
@article{Liu2021,
  author = {Liu, Yue and Yang, Chenguang and Qi, Wenyuan and Pei, Zuowei and Xue, Wei and Zhu, Huolan and Dong, Min and Guo, Ying and Cong, Duanduan and Wang, Fang},
  title = {The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects},
  journal = {Pharmacogenomics and Personalized Medicine},
  year = {2021},
  volume = {Volume 14},
  pages = {477--485},
  doi = {10.2147/pgpm.s291723}
}
Kostenlos starten →